search for




 

The Correlation of Plasma Endotoxin and Components of Systemic Inflammatory Response Syndrome in Terminally Ill Cancer Patients
Korean J Clin Geri 2013 Jun;14(1):39-48
Published online June 30, 2013
Copyright © 2013 The Korean Academy of Clinical Geriatrics.

Hoe Hyun Jung1, Ho-Min Yoon1, Youn Seon Choi1, June Young Lee2, Jong Eun Yeon3

Departments of 1Family Medicine, 2Biostatistics, 3Internal Medicine, Korea University College of Medicine, Seoul, Korea
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
 Abstract
Background: Most of terminally ill cancer patients died of multiple organ failure (MOF) preceding Systemic inflammatory response syndrome (SIRS). Serum endotoxin known as the cause of multiple organ failure and shock, stimulates the secretion of various cytokines and acute phase reactants. This study will investigate the correlation between the endotoxin and inflammation indices by the degree of the systemic inflammation of terminal cancer patients. Methods: Fifty-nine out of sixty-six terminally ill cancer patients referred to palliative care center, Korea University Guro Hospital from April 2009 to October 2009 were analyzed in this study. We performed correlation analysis between the plasma endotoxin and inflammation indices in the degree of the systemic inflammation. Results: As increasing the number of SIRS components, CRP were increased (r=.300, P<0.05) whereas lymphocyte was decreased(r=?.332, P<0.01). The plasma endotoxin and ESR do not demonstrate any significant correlations with the number of SIRS components. Conclusion: Lymphocyte, and CRP correlate with the degree of systemic inflammatory condition of terminally ill cancer patients. However, the plasma endotoxin concentration does not show the correlation with the states of systemic inflammation as well as with other inflammation indices.
Keywords : Terminal cancer patients, SIRS, MOF, Endotoxin, Inflammation indices

 

December 2022, 23 (2)